Clinical Trial Update: Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS [Phase 4]

View source ↗

Summary

Clinical trial update on Hemocontrol assessing its effectiveness in reducing long-term cardiovascular events in patients with chronic kidney disease; Phase 4 tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease

Drugs mentioned

• Hemocontrol

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Kidney Failure Chronic, Cardiovascular Diseases | Phase 4 | Status: UNKNOWN